Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.

McGorry PD, Nelson B, Phillips LJ, Yuen HP, Francey SM, Thampi A, Berger GE, Amminger GP, Simmons MB, Kelly D, Dip G, Thompson AD, Yung AR.

J Clin Psychiatry. 2013 Apr;74(4):349-56. doi: 10.4088/JCP.12m07785. Epub 2012 Nov 27.

PMID:
23218022
2.

Early intervention for psychosis.

Marshall M, Rathbone J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004718. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD004718.

PMID:
17054213
3.

Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.

Francey SM, Nelson B, Thompson A, Parker AG, Kerr M, Macneil C, Fraser R, Hughes F, Crisp K, Harrigan S, Wood SJ, Berk M, McGorry PD.

Schizophr Res. 2010 Jun;119(1-3):1-10. doi: 10.1016/j.schres.2010.02.1071. Epub 2010 Mar 26. Review.

PMID:
20347270
4.

Early intervention in patients at ultra high risk of psychosis: benefits and risks.

de Koning MB, Bloemen OJ, van Amelsvoort TA, Becker HE, Nieman DH, van der Gaag M, Linszen DH.

Acta Psychiatr Scand. 2009 Jun;119(6):426-42. doi: 10.1111/j.1600-0447.2009.01372.x. Epub 2009 Mar 10. Review.

PMID:
19392813
5.

Intervention in individuals at ultra-high risk for psychosis: a review and future directions.

McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rössler A, Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR.

J Clin Psychiatry. 2009 Sep;70(9):1206-12. doi: 10.4088/JCP.08r04472. Epub 2009 Jun 30. Review.

PMID:
19573499
6.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

7.

Young people at ultra high risk for psychosis: a research update.

Yung AR, Nelson B.

Early Interv Psychiatry. 2011 Feb;5 Suppl 1:52-7. doi: 10.1111/j.1751-7893.2010.00241.x. Review.

PMID:
21208392
8.

Serotonin and dopamine interactions in psychosis prevention.

Richtand NM, McNamara RK.

Prog Brain Res. 2008;172:141-53. doi: 10.1016/S0079-6123(08)00907-2. Review.

PMID:
18772031
9.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
10.

[Cognitive behavior therapy after first-episodes psychosis].

Lecardeur L.

Encephale. 2013 Sep;39 Suppl 2:S115-20. doi: 10.1016/S0013-7006(13)70106-4. Review. French.

PMID:
24084421
11.

Risperidone dose for schizophrenia.

Li C, Xia J, Wang J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007474. doi: 10.1002/14651858.CD007474.pub2. Review.

PMID:
19821422
12.

Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.

Müller H, Laier S, Bechdolf A.

Eur Arch Psychiatry Clin Neurosci. 2014 Nov;264 Suppl 1:S17-25. doi: 10.1007/s00406-014-0538-0. Epub 2014 Sep 27. Review.

PMID:
25261211
13.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):1-30. Review.

PMID:
15660702
14.

[Interventions in people at risk of developing first episode psychosis: a survey of current randomised controlled studies].

Müller H, Wießmann T, Bechdolf A.

Fortschr Neurol Psychiatr. 2012 Oct;80(10):570-9. doi: 10.1055/s-0032-1313038. Epub 2012 Oct 2. Review. German.

PMID:
23033203
15.

Is clinical intervention in the ultra high risk phase effective?

McGuire P, Selvaraj S, Howes O.

Rev Bras Psiquiatr. 2011 Oct;33 Suppl 2:s161-74. Review. English, Portuguese.

16.

Psychotherapy for adolescents and young adults at high risk for psychosis: a systematic review.

Okuzawa N, Kline E, Fuertes J, Negi S, Reeves G, Himelhoch S, Schiffman J.

Early Interv Psychiatry. 2014 Nov;8(4):307-22. doi: 10.1111/eip.12129. Epub 2014 Feb 27. Review.

PMID:
24576077
17.

Evidence-based early interventions for individuals at clinical high risk for psychosis: a review of treatment components.

Thompson E, Millman ZB, Okuzawa N, Mittal V, DeVylder J, Skadberg T, Buchanan RW, Reeves GM, Schiffman J.

J Nerv Ment Dis. 2015 May;203(5):342-51. doi: 10.1097/NMD.0000000000000287. Review.

PMID:
25919384
18.

Early interventions to prevent psychosis: systematic review and meta-analysis.

Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T.

BMJ. 2013 Jan 18;346:f185. doi: 10.1136/bmj.f185. Review. Erratum in: BMJ. 2013;346:f762.

19.

Psychosocial treatment for first-episode psychosis: a research update.

Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA.

Am J Psychiatry. 2005 Dec;162(12):2220-32. Review.

PMID:
16330584
20.

Predicting clinical response in people at ultra-high risk of psychosis: a systematic and quantitative review.

Mechelli A, Prata D, Kefford C, Kapur S.

Drug Discov Today. 2015 Aug;20(8):924-7. doi: 10.1016/j.drudis.2015.03.003. Epub 2015 Mar 18. Review.

Supplemental Content

Support Center